Skip to main content
Table of Contents
Print

Do neurotransmitter-related genes like DRD2 have roles in autism? 

Author: Lucia Alvarez, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Yes, neurotransmitter-related genes such as DRD2 are increasingly recognised as important contributors to autism’s neurological profile. These genes regulate the activity of neurotransmitters, chemical messengers that help brain cells communicate. Among them, dopamine is one of the most studied due to its central role in reward processing, motivation and movement. 

The DRD2 gene encodes a receptor for dopamine, and changes in this gene can alter how signals are transmitted across brain circuits. In some autistic individuals, variations in DRD2 and related genes have been linked to differences in social behaviour, attention, and emotional regulation, traits often affected in autism. These findings add to a broader understanding of how brain signalling pathways contribute to the condition’s diversity, especially when it comes to individual differences in motivation, sensory responses or learning styles. 

The Role of Dopamine and DRD2 in Autism 

Here are two ways neurotransmitter-related genes like DRD2 may influence autism traits: 

Modulate reward and social processing 

Dopamine pathways, influenced by DRD2, are involved in how we experience rewards, including social interaction. Changes in dopamine signalling may affect an autistic person’s interest in or response to social cues, contributing to differences in engagement or communication. 

Affect behavioural regulation and focus 

Abnormal dopamine receptor activity can impact how the brain manages attention and impulse control. Variants in genes associated with neurotransmitters may contribute to repetitive behaviours or difficulties in adapting to change.  

Investigating the influence of neurotransmitter-related genes helps refine how autism is understood, diagnosed and supported at the neurological level. Visit providers like Autism Detect for personal consultations and further guidance on screening and support. 

For a deeper dive into the science, diagnosis and full treatment landscape, read our complete guide to Genetic Influences.

Lucia Alvarez, MSc
Author

Lucia Alvarez is a clinical psychologist with a Master’s in Clinical Psychology and extensive experience providing evidence-based therapy and psychological assessment to children, adolescents, and adults. Skilled in CBT, DBT, and other therapeutic interventions, she has worked in hospital, community, and residential care settings. Her expertise includes grief counseling, anxiety management, and resilience-building, with a strong focus on creating safe, supportive environments to improve mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories